Pasithea Therapeutics (KTTA) Interest & Investment Income (2022 - 2026)
Pasithea Therapeutics recorded quarterly Interest & Investment Income of $450338.0 in Q1 2026, up 147.26% quarter-over-quarter from $182128.0 in Q4 2025, and up 853.2% year-over-year from $47245.0 in Q1 2025.
Pasithea Therapeutics' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $450338.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 853.2% year-over-year to $450338.0; the TTM figure through Mar 2026 stood at $730286.0 (up 130.22% YoY), while the FY2025 annual figure was $327193.0, down 22.68% from the prior year.
- Interest & Investment Income came in at $450338.0 for Q1 2026 at Pasithea Therapeutics, up from $182128.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $450338.0 in Q1 2026 to a low of -$335317.0 in Q3 2022.
- A 5-year average of $97496.9 and a median of $97445.0 in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income sank 69.16% in 2025 and surged 853.2% in 2026, its largest moves.
- Pasithea Therapeutics' Interest & Investment Income stood at -$335317.0 in 2022, then surged by 151.54% to $172825.0 in 2023, then tumbled by 53.43% to $80483.0 in 2024, then soared by 126.29% to $182128.0 in 2025, then jumped by 147.26% to $450338.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $450338.0, $182128.0, and $43396.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - | 450,338.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 450,338.00 |
| Dec 31, 2025 | 182,128.00 |
| Sep 30, 2025 | 43,396.00 |
| Jun 30, 2025 | 54,424.00 |
| Mar 31, 2025 | 47,245.00 |
| Dec 31, 2024 | 80,483.00 |
| Sep 30, 2024 | 75,076.00 |
| Jun 30, 2024 | 114,407.00 |
| Mar 31, 2024 | 153,218.00 |
| Dec 31, 2023 | 172,825.00 |
| Sep 30, 2023 | 131,740.00 |
| Sep 30, 2022 | -335,317.00 |